Background:This study investigated the molecular mechanisms of long non-coding RNAs (lncRNAs) in RSA using the lncRNA-miRNA-mRNA regulatory network.Methods: The present study obtained expression datasets of long non-coding RNAs (lncRNAs) (GSE179996), messenger RNAs (mRNAs) (GSE201469), and microRNAs (miRNAs) (GSE178619, GSE201442) from blood samples of individuals with RSA and healthy controls. The differentially expressed lncRNAs (DELs), mRNAs (DEMs), and miRNAs (DEmiRs) were revealed. Subsequently, the identi cation of miRNAs that interact with DELs and exhibit overlap with DEmiRs was conducted. The speci c genes were achieved through the overlapping predicted target genes and DEmiRs. A regulatory network comprising lncRNA, miRNA, and mRNA was established, followed by a subsequent analysis of enrichment. Also, the enrichment analysis was performed, and a protein-protein interaction (PPI) network was constructed.Results: This study identi ed 57 DELs, 212 DEmiRs, and 301 DEMs regarding RSA. Subsequent analysis revealed a lncRNA-miRNA-mRNA network comprising nine upregulated lncRNAs, 14 downregulated miRNAs, and 65 mRNAs. The ceRNA network's genes were then subjected to functional enrichment and pathway analyses, which showed their association with various processes, such as cortisol and thyroid hormone synthesis and secretion, human cytomegalovirus infection, and parathyroid hormone synthesis. Furthermore, ten hub genes (ITGB3, GNAI2, GNAS, SRC, PLEC, CDC42, RHOA, RAC1, CTNND1, FN1) were identi ed based on the PPI network results.
Conclusion:In summary, the outcomes of our study offer new understandings towards comprehending the potential pathogenic mechanism in RSA via the lncRNA-miRNA-mRNA network and reveal the possibility of identifying new lncRNAs and miRNAs as promising molecular biomarkers.